Michael Mason's Net Worth
Michael Mason's net worth is estimated to be at least $10,062,193.32 as of 11/22/2024. CoreStreet's estimation of Michael Mason's net worth is based on their sale of stock and current holding of stock.
Michael Mason is CFO at Karyopharm Therapeutics Inc. They have executed at least 14 trades of stock as per SEC Form 4 filings. Their most recent trade was for 652 units of KPTI stock on 06/04/2024. Their biggest sale was on 01/04/2018 when they sold 36,745 units of Alnylam Pharmaceuticals Inc stock for $4,835,274.55. They typically trade 2 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $10,062,193.32
Most recent insider trade:
- June 4, 2024
Michael Mason's Insider Trading History
| Karyopharm Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 4, 2024 | CFO | 652 | $0.99 | Sell | $645.48 |
Feb. 29, 2024 | CFO | 27,687 | $1.17 | Sell | $32,393.79 |
Feb. 27, 2024 | CFO | 2,545 | $1.32 | Sell | $3,359.40 |
Feb. 6, 2024 | CFO | 4,205 | $1.59 | Sell | $6,685.95 |
Sept. 1, 2023 | CFO | 6,913 | $1.33 | Sell | $9,194.29 |
March 1, 2023 | CFO | 11,205 | $3.03 | Sell | $33,951.15 |
June 3, 2022 | CFO | 601 | $6.04 | Sell | $3,630.04 |
Feb. 7, 2022 | CFO | 3,947 | $9.86 | Sell | $38,917.42 |
| Alnylam Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 4, 2018 | VP | 36,745 | $131.59 | Sell | $4,835,274.55 |
May 16, 2017 | VP | 9,375 | $70.00 | Sell | $656,250.00 |
Dec. 15, 2014 | VP | 22,162 | $97.50 | Sell | $2,160,795.00 |
July 12, 2013 | VP | 14,200 | $50.00 | Sell | $710,000.00 |
July 1, 2013 | VP | 27,000 | $32.00 | Sell | $864,000.00 |
June 17, 2013 | VP | 23,625 | $29.93 | Sell | $707,096.25 |